Myomectomy During Cesarean Section

Cesarean Myomectomy : Safety and Risk of Intrauterine Synechiae

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03095014

Enrollment

Registered

2017-03-29

Start date

2010-01-31

Completion date

2016-10-31

Last updated

2017-03-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myomectomy

Brief summary

Cesarean Myomectomy, safety and effect on uterine cavity.

Detailed description

this study aims to compare between women who underwent Cesarean Myomectomy and those who underwent Cesarean section only regarding the procedure safety and whether uterine cavity was affected later on.

Interventions

PROCEDURECesarean Myomectomy

Myomectomy was done during Cesarean section

PROCEDURECesarean section

Cesarean delivery

Study design

Allocation

NON_RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Intervention model description

Cesarean Myomectomy

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 45 Years

Healthy volunteers

Yes

Inclusion criteria

* pregnant * full term * had uterine myoma

Exclusion criteria

* history of coagulation disorder * antepartum hemorrhage * previous myomectomy * where additional operative procedures were performed

Design outcomes

Primary

Measure	Time frame	Description
Mean change in Haemoglobin in gm/dl	24 hours	pre-operative Haemoglobin minus post-operative Haemoglobin level

Secondary

Measure	Time frame	Description
Duration of operation in hours	2 hours	time to complete the procedure
intrauterine adesion adhesions	3 months	presence of uterine cavity adhesions

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026